TW200928357A - A device for detecting the dioxin and a method of detection thereof - Google Patents

A device for detecting the dioxin and a method of detection thereof Download PDF

Info

Publication number
TW200928357A
TW200928357A TW96150572A TW96150572A TW200928357A TW 200928357 A TW200928357 A TW 200928357A TW 96150572 A TW96150572 A TW 96150572A TW 96150572 A TW96150572 A TW 96150572A TW 200928357 A TW200928357 A TW 200928357A
Authority
TW
Taiwan
Prior art keywords
dioxin
electrode
detection method
hydrocarbon receptor
detection
Prior art date
Application number
TW96150572A
Other languages
Chinese (zh)
Other versions
TWI368028B (en
Inventor
Hung-Chang Wu
Chao-Kuo Liu
Tze Khai Lin
Chin-Fan Lu
Shin-Chong Tsai
Koun-Jou Wei
Pearl Hsiu-Ping Lin
Original Assignee
Dev Center Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dev Center Biotechnology filed Critical Dev Center Biotechnology
Priority to TW096150572A priority Critical patent/TWI368028B/en
Priority to JP2008179268A priority patent/JP2009156859A/en
Publication of TW200928357A publication Critical patent/TW200928357A/en
Application granted granted Critical
Publication of TWI368028B publication Critical patent/TWI368028B/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates a device for detecting the dioxin and a method of detection thereof. The method of the present invention is based on the bio-affinity, which comprises contacting the detecting device with the sample containing the dioxin or dioxin-like compounds, and the shield-effect on the surface of electrode is produced by utilizing the affinity between the bio-recognized element on the electrode of the said device and the dioxin or dioxin-like compounds, and then detects current difference between the device contacting with the dioxin or dioxin-like compounds before and after. Finally, the concentration of the dioxin or dioxin-like compounds of the samples are determined by comparing the current difference data with the concentration of dioxin and dioxin-like compounds of standard solutions and the corresponding current difference.

Description

200928357 九、發明說明: 【發明所屬之技術領域】 本發明係關於—種戴奥辛檢測方法及其所使用之檢測 特別是關於—種㈣快速、可現地檢測之電化學式 戴奥辛檢測裝置及使用其之戴奥辛檢測方法。 【先前技術】 戴奥辛被稱為世紀之毒,係因具急毒性,人類暴露於 ❸戴奥辛所導致之病變或生理異常多為極微量的暴露。依據 文獻所載,戴奥辛的毒性包括皮膚毒性、神經系統毒性、 肝臟毒性、腫瘤、生殖系統毒性等。戴奥辛產生的來源包 括自然生成(如火山爆發、森林火災)、工業原料製程(如含 .氣酚類化合物)的副產物、特定工業製程的燃燒排放(工業高 溫製程、化學製造、電力與能源利用)及其他人為的燃燒行 為(如露天燃燒、火災、抽煙等)。戴奥辛不只存在於空氣中 ,也同時存在於土壤與底泥中。它可經由呼吸和食入而影 ❹響人類及動物的健康。然而,戴奥辛進入人體及動物的途 徑主要是經由食物攝取而來,主要來自高脂肪食物如魚、 肉類和牛乳。基於對環境的保護與人體健康的防衛,戴奥 辛的偵測已成為當前相當重要的課題。 傳統戴奥辛類化合物的檢測技術主要係利用高效率氣 相層析儀-質譜儀(HRGC-MS)進行分析;近幾年荷蘭 BDS(Bi〇 Detection Systems)公司發展出一新穎的生物篩選 法’即戴奥辛反應化學活化冷光酶表現(DR-CALUX(Di〇xin200928357 IX. Description of the invention: [Technical field of invention] The present invention relates to a method for detecting dioxin and the detection thereof, in particular to an electrochemical dioxin detection device for rapidly and reproducibly detecting (4) and using the dioxin Detection method. [Prior Art] Dioxin is known as the poison of the century. Because of its acute toxicity, human exposure to ❸戴奥辛 results in very small lesions or physiological abnormalities. According to the literature, the toxicity of dioxin includes dermal toxicity, neurotoxicity, liver toxicity, tumor, reproductive system toxicity and the like. Sources of dioxin include natural generation (eg volcanic eruptions, forest fires), by-products of industrial raw materials processes (eg, gas-containing phenolic compounds), and combustion emissions from specific industrial processes (industrial high-temperature processes, chemical manufacturing, electricity and energy use) ) and other people's burning behavior (such as open burning, fire, smoking, etc.). Dioxin is not only found in the air, but also in the soil and sediment. It can affect the health of humans and animals through breathing and ingestion. However, Dioxin's access to the human body and animals is mainly through food intake, mainly from high-fat foods such as fish, meat and milk. Based on the protection of the environment and the defense of human health, the detection of Dioxin has become a very important topic at present. Traditional dioxin-based detection techniques are mainly analyzed by high-efficiency gas chromatography-mass spectrometry (HRGC-MS); in recent years, BDS (Bi〇Detection Systems) of the Netherlands has developed a novel biological screening method. Dioxin reaction chemical activation cold light enzyme performance (DR-CALUX(Di〇xin)

Response Chemical Activated Luciferase expression))檢測 6 200928357 法,用於類戴奥辛物質檢測。然而,此兩種主要檢測技術 因設備成本高、檢測時間長及使用方便性不佳等因素,致 使無法直接應用於現地檢測;因此,對於開發出一套設備 成本低、檢測時間短及方便使用的戴奧辛快速檢測平台, 可直接應用於現地環境檢測與食品的檢測方法及裝置是極 為需要的。 t 詳言之,目前戴奥辛檢測技術主要可以分為二類,最 ❹,要以及最常用的方法為化學分析法,化學分析法即利用 局效率氣相層析儀/質譜儀(HRGC/HRMS)進行分析各種類 戴奥辛物質,其主要原理係利用戴奥辛類各化合物間,分 '子大小、帶電性、質量、極性等差異,將不同戴奥辛分子 *分離開來;其最大的優點在於可以具體且明確地界定各戴 奥辛類相似物、準確性高、選擇性高、分析極限達(百 兆分之一(partspertrim〇n))等級’並可藉由國際標準化 的毒性當量因子(TEF),換算成毒性當量(TEQ),常用作一 ❹般檢測^術之對照組。由於生物檢體樣本前處理十分困難 ,,上尚解析力之氣相色層分析儀與高解析質譜儀器購置 及管理不易,目前世界上認定有能力正確分析環境檢體中 之微量PCDDs (多氣代二苯并-對·戴奥辛(p〇lychl〇ri瞻d dibenz〇-p-di〇Xins ))與 PCDFs (多氯代二苯并呋喃( Polychlorinated dibenzofurans))的實驗室非常有限,導致 戴奥辛分析不僅費時且價格昂貴,同時分析結果缺乏生物 毒性或是與生物間相互作用方面的資訊。 另一類戴奥辛檢測技術為生物分析法,此檢測技術常 7 200928357 藉由細胞中芳香烴受體(aryl hydrocarbon receptor,AHR)與 戴奥辛類化合物之毒性機制,如CALUX分析法,其將老鼠 肝癌H4IIE細胞株中接上具螢火蟲冷光基因(luciferase gene)之質體(plasmid)作為報告基因(reporter)。當戴奥辛類 化合物啟動細胞核内DNA上戴奥辛類反應元素(dioxin responsive elements,DREs)之片段基因時,同時也啟動冷光 基因,使細胞產生冷光酵素,而冷光酵素催化冷光素發出 _ 冷光,最後藉由冷光之強弱與戴奥辛毒性產生之冷光強度 比較即可推算出戴奥辛之含量,目前國内環檢所也已利用 此方法進行戴奥辛污染物分析。此外,AHH/EROD分析法 則是藉由分析細胞中AHR與戴奥辛類化合物之毒性機制的 產物p450,來推算出戴奥辛含量。其它的生物分析法,則 常藉由抗體與戴奥辛類化合物之結合機制,進行戴奥辛含 量分析,如酵素免疫試驗(enzyme immunoassay,EIA)分析 法及表面電漿共振效應(surface plasma response,SPR)分析 法則是利用能與戴奥辛結合的抗體進行分析;而AHR-DNA ® 結合之凝膠遲滯(gel retardation of AHR-DNA binding, GRAB )分析法,則是藉由經戴奥辛類化合物誘導的AHR ,結合到放射線標的DRE上進行分析。Mitsunobu et al.(2004)以自行篩選的單株抗體建構(酵素連結免疫吸附試 驗(Enzyme-Linked Immunosorbent Assay,ELISA))來偵 測人類乳汁中戴奥辛異構物族群,指出該系統的偵測範圍 可介於1-100 pg/assay之間,而偵測極限相對於2,3,7,8-四 氯二聯苯戴奥辛(2,3,7,8-tetrachlorodibenzo-/7-dioxin 8 200928357 ,TCDD)更低至1 pg/assay,但仍然不能避免ELISA試驗前 處理過於冗長的問題,導致分析的時間過長;Nakamura et al.篩選可與戴奥辛相結合的胜肽(peptide),將帶有胜狀的 1珠懸浮於含有螢練示的3,4•二氣苯氧基丙胺緩衝溶液 中,再以其债測樣本中的戴奥辛濃度,當戴奥辛濃度越高 ,則螢光的亮度越低,整體的偵測極限小於lnM,此法除 了 4貞測極限不夠低之外,真實樣本中其他物質的干擾是最 ❹主要的問題,同時反應時間過長與訊號判讀是另一困難點 人^ (2〇〇3)則利用金表面電浆共振效應(SPR)結 1 貞測錄亦不夠低,無法作為線上即時監控之用。此: asaharu等人(方⑽化沒她心c,· / 14, 137-340)利用 AHR 在戴奥辛 ; =角色,將其固定在電極上,利用電反 ❹辛奈結合前後輸出電流《的 m奥辛偵測系統。此系統不僅所需的作用時 可惜的糸統的構造亦極為簡單,便於操作,較為 系統的靈敏度仍不夠,且存在AH 季今 產品商業化困儀偵測模式過於昂貴複雜,導致 生物感測器(Bi〇sensor)在 化學儀器分析方法,其最大的特^兄:;測上,相較於傳統 型態,同時減少;”、疋可以设計成可拋棄式 樣本則處理步驟。此外,由於其檢測設備 9 200928357 相當簡單^:因而I在現地直接操作。生物感測器在環境檢 測方面,申見的分析物如毒性物質、農藥、热、 酚類、重金屬、微生物、無機磷夕# = 、 σ 豕、 測極限從0.1 ng/L到〇.57 /L 貝再價Response Chemical Activated Luciferase expression)) Test 6 200928357 Method for the detection of dioxin-like substances. However, due to factors such as high equipment cost, long detection time and poor usability, these two main detection techniques cannot be directly applied to the local inspection; therefore, the development of a set of equipment is low in cost, short in detection time and convenient to use. The dioxin fast detection platform is directly applicable to local environmental testing and food detection methods and devices. t In detail, the current Dioxin detection technology can be divided into two categories, the most embarrassing, and the most commonly used method is chemical analysis, chemical analysis method is to use the local efficiency gas chromatography / mass spectrometer (HRGC / HRMS) Analyze various types of dioxin-like substances, the main principle is to separate the different dioxin molecules* by using the differences in 'sub-size, chargeability, mass and polarity'. The biggest advantage is that it can be specific and clear. Defining each of the dioxin analogs with high accuracy, high selectivity, analytical limit (partspertrim〇n) grade and can be converted to toxicity by internationally standardized toxicity equivalent factor (TEF) Equivalent (TEQ), often used as a control group for the same test. Due to the difficulty in pre-treatment of biological samples, it is not easy to purchase and manage high-resolution mass spectrometers. It is currently recognized in the world to be able to correctly analyze trace amounts of PCDDs in environmental samples. The laboratories of dibenzo-p-dioxin (p〇lychl〇ri d dibenz〇-p-di〇Xins) and PCDFs (polychlorinated dibenzofurans) are very limited, leading to dioxin analysis. Not only is it time consuming and expensive, but the analysis results in information on biological toxicity or interactions with organisms. Another type of dioxin detection technology is bioanalysis. This detection technique is often 7 200928357. By using the toxic mechanism of aryl hydrocarbon receptor (AHR) and dioxin-like compounds in cells, such as CALUX analysis, it will be used to treat mouse liver cancer H4IIE cells. A plasmid with a luciferase gene was used as a reporter. When the dioxin-like compound initiates the fragment gene of dioxin responsive elements (DREs) on the DNA in the nucleus, it also activates the cold-light gene, which causes the cells to produce luminescent enzymes, while the luminescent enzyme catalyzes the luminescence of luminescent light. The intensity of cold light and the intensity of luminosity caused by the toxicity of dioxin can be used to calculate the content of dioxin. At present, the domestic environmental inspection institute has also used this method to analyze the dioxin. In addition, the AHH/EROD assay is based on the analysis of the product p450 of the toxic mechanism of AHR and dioxin in cells to derive the dioxin content. Other bioassays often perform dioxin content analysis, such as enzyme immunoassay (EIA) analysis and surface plasma response (SPR) analysis, by the binding mechanism of antibodies to dioxins. The rule is to use an antibody that binds to dioxin, and the AHR-DNA ® gel retardation of AHR-DNA binding (GRAB) assay is based on AHR induced by dioxin-like compounds. The analysis was performed on the radiographic target DRE. Mitsunobu et al. (2004) used a self-screening monoclonal antibody construct (Enzyme-Linked Immunosorbent Assay (ELISA)) to detect the dioxin isomer group in human milk, indicating the detection range of the system. It can be between 1-100 pg/assay, and the detection limit is relative to 2,3,7,8-tetrachlorodiphenyl-dioxin (2,3,7,8-tetrachlorodibenzo-/7-dioxin 8 200928357 , TCDD) is as low as 1 pg/assay, but it still cannot avoid the problem of too long ration before the ELISA test, which leads to too long analysis; Nakamura et al. screens peptides that can be combined with dioxin. The winning bead is suspended in a buffer solution containing 3,4 • diphenoxyphenamine in serotonin, and the concentration of dioxin in the sample is measured. The higher the concentration of dioxin, the lower the brightness of the fluorescent light. The overall detection limit is less than lnM. In addition to the fact that the detection limit is not low enough, the interference of other substances in the real sample is the most important problem. At the same time, the reaction time is too long and the signal interpretation is another difficult point. (2〇〇3) uses gold surface plasma resonance The (SPR) knot 1 贞 test record is not low enough to be used for online real-time monitoring. This: asaharu et al. (Party (10) does not have her heart c, · / 14, 137-340) using AHR in Dioxin; = role, fixed it on the electrode, using electric reverse ❹ 辛奈 combined before and after output current "m Ossing detection system. This system not only has the required function, but also has a very simple structure, which is easy to operate, and the sensitivity of the system is still not enough. Moreover, the commercial mode of the AH product is too expensive and complicated, resulting in a biosensor. (Bi〇sensor) In the chemical instrument analysis method, its largest special brother:; measured, compared to the traditional type, at the same time reduced;", 疋 can be designed as a disposable sample processing step. In addition, due to its Testing equipment 9 200928357 is quite simple ^: thus I operate directly in the field. Biosensors in the field of environmental testing, such as toxic substances, pesticides, heat, phenols, heavy metals, microorganisms, inorganic phosphorus # = # = , σ 豕, the limit of measurement from 0.1 ng / L to 〇.57 / L shell re-price

Anal Bioanal Chem 386 : 1〇25_104^ ^ (2〇〇6) 口此本發明主要在於提供—種簡易快速之戴奥辛檢 測方法,及該方法使用之電化學戴奥辛檢測裝置,經由該 快^化學式戴奥辛檢測裝置’可直接應用於現地』檢 測與食品的檢測’達到省時、經濟與現地快速大量筛=之 目的。 【發明内容】 發明摘述 本發明的主要目的在於開發一簡易快速之電化學戴奥 辛檢測裝置,其主要原理乃利用生物親和型(bioaffinity)生 物感測器的偵測型態,搭配網印電極( SCreen-pril^ed_electr〇de,咖)電極將生物辨認元件(ahr 或ARNT(彡香文體核轉位蛋白(町1 hyd刚㈣⑽咖⑹ translocator)))以物理或化學方法固定於電極表面上利用 土物:認元件與戴奥辛類化合物或其複合物產生親和性結 ^造成電極表面生物A子形片大改變或厚度改冑,形成遮 蔽效應,‘致電子傳輸速率改變,再經由電極上原有的電 子媒"2與外加的基質進行氧化還原反應而產生電流變化 ’經測得丨電流變化值,冑其與反應的戴奥辛類化合物濃 度加以相關’求得各戴奥辛類化合物濃度與電流下降率的 200928357 關係,以所建立之相關式進行戴她 — 根據本發明之快速電化學式戴奥辛疋置。因此, 、經濟與快速大量篩檢之目的。 d裝置,可達到省時 發明詳細說明 :本發明之一目的在提供-種戴奥辛檢測方法,其包含 ❹ ❹ ⑴:生物辨認元件及一電子媒介物固定於一電極 (2)極置於含基質之溶液t,測量第一氧化還 原電流訊號; 不孔化還 (3 與含戴奥辛或類戴奥辛物質樣本接觸, 電極置於含基質之溶液中,測量第二 原電流訊號;及 (4) 獲得第-及第二氧化還原電流訊號差值,並與含 戴奥辛或類戴奥辛物質之標準溶液及其相對應電 流訊號差值比較’決定該樣本中戴奥辛或類g奥 辛物質之濃度。 、 在本發明中,使用作為本發明電極之材料並無特別限 制八要夠達到本發明之目的而不具有不良結果者均可 應用在本發明,其可包括例如氧化銦、玻璃、金、白金、 鈀、石墨及碳黑等材料。在電極結構方面,無論是平板電 極、實心針狀電極或鏤空針狀電極等結構均可應用在本發 明。在本發明之一具體實施例中,該電極為網印電極。 在本發明中’對於固定於電極表面之生物辨認元件並 200928357 無特別限制,只要能與戴奥辛或類戴奥辛物質專一性結合 之親戴奥辛物質即可,較佳為單株抗體、多株抗體、多胜 肽、芳香烴受體(AHR)及/或芳香烴受體核轉位蛋白(ARNT) ,更佳為芳香烴受體及芳香烴受體核轉位蛋白。 在本發明中,固定於電極表面之電子媒介物並無特別 限制,只要與下文所述之基質產生氧化還原反應,產生電 子轉移即可,較佳之電子媒介物係選自普魯士藍(Prussian Blue,potassium hexacyanoferrate)、麥爾多拉氏藍(Meldola Blue,MB,8-dimethylamino-2,3_benzophenoxazine)、對苯酉昆 (p-Benzoquinone; p-BQ)、鄰苯二胺(o-phenylenediamine ;o-PDA)、二氯紛散基盼(dichlorophenolindophenol DCPIP) 、3,4-二經苯曱搭(3,4_(1111}^(11'〇父}^6112已1(1611丫(16;3,4-01^)、 苯曱基紫精(benzyl viologen)、及其混合物所組成之群組 〇 在本發明中,對於該基質並無特別限制,只要與上文 所述之電子媒介物產生氧化還原反應,發生電子轉移即可 ,較佳之基質為H202、NADH、NADPH及/或其混合物, 更佳為H202。 本發明之另一目的在提供一種戴奥辛檢測裝置,其包 含: 一基板; 一參考電極,其係位於該基板上;及 一工作電極,其係位於該基板上且不與該參考電極接 觸,該工作電極包括一工作區域,該工作區域中含有 12 200928357 生物辨認元件及電子媒介物。 之材:戴奥辛檢測裝置中,使用作為本發明電極 有不Μ果、ί ’只要能夠達到本發明之目的而不具 二者均可應用於本發明,其可包括氧化銦、玻璃 ❹Anal Bioanal Chem 386 : 1〇25_104^ ^ (2〇〇6) The present invention mainly provides a simple and rapid method for detecting dioxin, and the electrochemical dioxin detection device used in the method, through the fast chemical dioxin detection The device 'can be directly applied to the local inspection and food inspection' to achieve time-saving, economic and local rapid screening. SUMMARY OF THE INVENTION The main object of the present invention is to develop a simple and fast electrochemical dioxin detection device whose main principle is to use a detection mode of a bioaffinity biosensor with a screen printing electrode ( The SCreen-pril^ed_electr〇de, coffee) electrode uses a biometric element (ahr or ARNT (the scent of the scent of the scent of the scent of the scent of the scent of the scent of the scorpion) to be fixed to the surface of the electrode by physical or chemical means. Soil: The identification of the component and the dioxin-like compound or its complex produces an affinity. The surface of the electrode has a large change in the surface of the bio-A sub-sheet or a change in thickness, forming a shadowing effect, which causes the electron transfer rate to change and then passes through the original electrode. The electronic medium "2 and the additional matrix undergo redox reaction to produce a current change 'measured 丨 current change value, which is related to the concentration of the reacted dioxin compound' to obtain the concentration and current drop rate of each dioxin compound 200928357 Relationship, wearing her in the established correlation - a fast electrochemical dioxin device according to the invention. Therefore, the purpose of economic, and rapid screening. d device, can achieve time-saving invention Detailed Description: One object of the present invention is to provide a method for detecting dioxin, which comprises ❹ ❹ (1): a biometric component and an electron carrier are fixed to an electrode (2) Solution t, measuring the first redox current signal; not puncturing (3 contact with the dioxin-containing or dioxin-like material sample, the electrode is placed in the matrix-containing solution, measuring the second original current signal; and (4) obtaining the first - and the second redox current signal difference value, and compared with the standard solution containing dioxin or dioxin-like substance and its corresponding current signal difference 'determines the concentration of dioxin or g-octin-like substance in the sample. The use of the material as the electrode of the present invention is not particularly limited. It can be applied to the present invention without the disadvantages of the present invention, and may include, for example, indium oxide, glass, gold, platinum, palladium, graphite. And materials such as carbon black. In terms of electrode structure, any structure such as a flat electrode, a solid needle electrode or a hollow needle electrode can be applied to the present invention. In one embodiment, the electrode is a screen printing electrode. In the present invention, the biometric element fixed to the electrode surface and 200928357 is not particularly limited as long as it can be combined with dioxin or dioxin-like material specificity. Preferably, it is a monoclonal antibody, a multi-drug antibody, a multi-peptide, an aromatic hydrocarbon receptor (AHR) and/or an aromatic hydrocarbon receptor nuclear translocator (ARNT), more preferably an aromatic hydrocarbon receptor and an aromatic hydrocarbon. In the present invention, the electron mediator immobilized on the surface of the electrode is not particularly limited as long as it produces a redox reaction with a substrate described below to produce electron transfer. Preferably, the electron mediator is selected from the group consisting of Prussian Blue (potusium hexacyanoferrate), Meldola Blue (MB, 8-dimethylamino-2, 3_benzophenoxazine), p-Benzoquinone (p-BQ), o-phenylenediamine O-phenylenediamine; o-PDA), dichlorophenolindophenol DCPIP, 3,4-dibenzopyrene (3,4_(1111}^(11'〇父}^6112已1(1611丫(16;3,4-01^), benzoquinone violet A group consisting of benzyl viologen) and a mixture thereof is not particularly limited in the present invention, as long as electron transfer occurs with the electron mediator described above, and electron transfer occurs, preferably a substrate. More preferably H202, NADH, NADPH and/or a mixture thereof, more preferably H202. Another object of the present invention is to provide a dioxin detection apparatus comprising: a substrate; a reference electrode on the substrate; and a work An electrode is disposed on the substrate and is not in contact with the reference electrode, and the working electrode includes a working area containing 12 200928357 biometric components and an electronic medium. In the dioxin detecting device, the use of the electrode of the present invention as a result of the present invention may be applied to the present invention as long as it can achieve the object of the present invention, and may include indium oxide or glass ruthenium.

G 益…、石墨及碳黑等材料。在電極結構方面, =用在本發明。在-較佳具體實施例中,該電夂::: ㈣2發明之戴奥辛檢測裝置中,該生物辨料件並無 =制,只要能與戴奥辛或類戴奥人: '戴奥辛物質即可,較佳為單株抗體、多株抗體 4及:=體及/或芳香烴受體核轉位蛋白,更佳為芳香烴 又體及方香烴受體核轉位蛋白。 別ρρΐ本^之戴奥辛檢測裝置中’該電子媒介物並無特 路:i能與本文中所述之基質產生氧化還原反應, :生電子轉移即可’較佳之電子媒介物係選自普魯士藍、 麥爾:拉氏藍、對苯酿、鄰苯二胺、二氯酚靛基紛、3,4_ 技r本甲冑苯甲基紫精、及其混合物所組成之群組,更 佳為普魯士藍。 妒趿在t發明之戴奥辛檢測裝置中,可將該電子媒介物與 ^膠以適^之比例混合而網印於基板上,比例可視需要而 調整,電子媒介物比例越高電流值越大。 、在本發明之戴奥辛檢測裝置中,該生物辨認元件可例 如以物理包埋、共價結合等適當方法固定於基板之工作區 13 200928357 域上。物理包埋係例如將芳香烴受體或芳香烴受體核轉位 蛋白與明膠' 纖維素、合成黏土拉波尼特(Laponite )或聚 乙烯醇縮丁醛(PVB )等適當之溶液,以適當比例混合後 ,取適當量固定於工作區域上。共價結合則例如將榖胱甘 肽(Glutathione,GSH)與明膠或纖維素以適當比例混合後 ,取適當量固定於工作區域,之後再將芳香烴受體或芳香 烴文體核轉位蛋白以浸泡或滴上之模式固定至該工作區域 。由於本發明所生產之芳香烴受體與芳香烴受體核轉位蛋 白均具有GST終端,其可與已固定之榖胱甘肽形成緊密結 ^。上述二種方法中以共價結合較佳,因共價結合可確保 芳香烴受體或芳香烴受體核轉位蛋白均位於電極表面,因 而可提升有效固定量與結合位之數目。 二-在本發明之戴奥辛檢測裝置中,須以適當量之生物辨 =7^固定於該工作區域中。若卫作區域中之生物辨認元 4 3量太 >、,則無法阻礙電子流動而凸顯電流下降差異. ❹ 2太多則導致電極表面—開始便過於密實,即後戴 奥辛ΐ類戴奥辛分子吸附上去,仍舊無法凸顯電流下4 以方香烴嗳體或芳香烴受體核轉位蛋白為例,固定於工 2域之含量較佳為。,圭 21.43ng/mm2〜〇.13pg/mm2。 馬 戴奧在提供一種利用戴奥辛檢測裝置之 孰興辛檢測方法,其中該戴奥辛檢測裝置 一基板; 一參考電極,其係位於該基板上;及 14 200928357 一工作電極,其係位於該基板上且不與該參考電極接觸 口亥工作電極包括—卫作區域’該卫作區域中含有生物 辨認元件及電子媒介物,·且 该戴奥辛檢測方法包含: (1) 將該戴奥辛檢測裝置置於含基質之電化學緩衝液 中偵測其電流訊號△ 1〇 ; (2) 將該戴奥辛檢測裝置與檢測樣本接觸,並於含基 質之電化學緩衝液中偵測其電流訊號么乙;" (4) ’ °、測得△ 1〇與△ L電流訊號差值; =该電流訊號差值與含戴奥辛或類戴奥辛物質之 標準溶液及其相對應電流訊號差值比較,以決定 該樣本中戴奥辛或類戴奥辛物質之 在本發明之戴奥辛檢測方法中,本發明對=步驟(ι) 土⑺所使用之基質並無特別限制,只要與上文所述 媒’I物產生氧化還原反應,發生電子轉移即可, 基質為H2〇2、NADH、NADpH及/或其混合物較佳為邮2G benefits..., graphite and carbon black. In terms of electrode structure, = is used in the present invention. In a preferred embodiment, the electroacupuncture::: (4) 2 in the Dioxin detecting device of the invention, the biometric material is not in the system, as long as it can be used with Dioxin or the Dior: "Dioxin substance, Preferably, the monoclonal antibody, the multi-drug antibody 4 and the := body and/or aryl hydrocarbon receptor nuclear transposable protein, more preferably an aromatic hydrocarbon and a fragrant hydrocarbon receptor nuclear translocator. In the Dioxin detection device, there is no special way for the electron mediator: i can generate a redox reaction with the substrate described herein: bioelectron transfer can be used. The preferred electron mediator is selected from Prussian blue. , Maier: Lacto blue, p-benzene, o-phenylenediamine, dichlorophenol fluorenyl, 3,4_ techno, methicone, and mixtures thereof, preferably Prussian blue. In the dioxin detection device invented by t, the electronic medium can be mixed with the glue at a suitable ratio and screen printed on the substrate, and the ratio can be adjusted as needed. The higher the proportion of the electronic medium, the larger the current value. In the dioxin detecting device of the present invention, the biometric element can be fixed to the working area 13 200928357 of the substrate by a suitable method such as physical embedding or covalent bonding. The physical embedding system is, for example, an appropriate solution of an aromatic hydrocarbon receptor or an aromatic hydrocarbon receptor nuclear translocator with gelatin 'cellulose, synthetic clay Laponite or polyvinyl butyral (PVB). After mixing in an appropriate ratio, the appropriate amount is fixed on the work area. For covalent binding, for example, glutathione (GSH) is mixed with gelatin or cellulose in an appropriate ratio, and then fixed in an appropriate amount in the working area, followed by an aromatic hydrocarbon receptor or an aromatic hydrocarbon nucleocapsid transposable protein. The mode of soaking or dripping is fixed to the work area. Since the aromatic hydrocarbon receptor produced by the present invention and the aryl hydrocarbon receptor nuclear translocation protein both have a GST terminal, they can form a tight junction with the immobilized glutathione. Covalent bonding is preferred in both of the above methods, and covalent bonding ensures that the aromatic hydrocarbon acceptor or the aromatic hydrocarbon receptor nuclear translocator is located on the surface of the electrode, thereby increasing the effective immobilization amount and the number of binding sites. Second, in the dioxin detecting device of the present invention, it must be fixed in the working area with an appropriate amount of biological data. If the amount of biometric identification in the satellite area is too large, it will not hinder the flow of electrons and highlight the difference in current drop. 太多 2 too much will cause the surface of the electrode to be too dense, that is, the dioxin-like Dioxin molecule adsorption Up, it is still impossible to highlight the current under the current 4 fragrant hydrocarbon steroid or aryl hydrocarbon receptor nuclear translocator as an example, the content fixed in the 2 field is preferably. , Gui 21.43ng/mm2~〇.13pg/mm2. Ma D'Ao provides a method for detecting a Dickinson using a dioxin detection device, wherein the dioxin detection device is a substrate; a reference electrode is disposed on the substrate; and 14 200928357 a working electrode is disposed on the substrate The contact electrode does not contact the reference electrode, and the working area includes a biometric component and an electronic medium, and the Dyson detection method comprises: (1) placing the dioxin detection device in the matrix (2) contacting the dioxin detection device with the test sample and detecting the current signal in the electrochemical buffer containing the matrix; " (4) ) ° °, measured Δ 1 〇 and Δ L current signal difference; = the current signal difference is compared with the standard solution containing dioxin or dioxin-like substance and its corresponding current signal difference to determine the sample in the sample dioxin or In the dioxin-detecting method of the present invention, the present invention has no particular limitation on the substrate used in the step (1) soil (7), as long as it is The medium 'I substance produces a redox reaction, and electron transfer may occur. The substrate is H2〇2, NADH, NADpH and/or a mixture thereof is preferably postal 2

之工=?之;奥辛檢測方法中’對於戴奥辛檢測裝置 上,該工作區域中所含之生物辨認元件並無特 ϋ制’只要能與戴奥辛或類戴奥辛物 U ί;,物質即可,較佳為單株抗體、多株抗艘、二親 ==及/或芳香煙受雜核轉位蛋白,更佳為芳香煙 體及方香烴受體核轉位蛋白。 在本發明之-具體實施例中,該戴奥辛檢測敦置之工 200928357 作電極的工作區域中包含芳香烴受體核轉位蛋白。由於芳 香烴受體核轉位蛋白專一性與芳香烴受體-戴奥辛複合物相 結合,因此步驟(2 )可修正為:將檢測樣本先與過量芳香 烴受體反應,再將該戴奥辛檢測裝置與該檢測樣本接觸, 並於含基質之電化學緩衝液中偵測其電流訊號△ I i。 經由下述詳述之實施例並參照相關圖式,本發明在前 述及其他相關目的、特徵和優點會而更顯清楚。 【實施方式】 實施例1芳香烴受體製備 本實施例所使用之培養基及緩衝液如下: (1) 蛋白質表現所用的培養基,LB培養基、安比西林 (Ampicillin ; Amp)(最終濃度 100 pg/ml)、氯黴素 (Cm)(最終濃度 34Hg/ml)。 (2) LB培養基··腺蛋白脒(Tryptone ) 10 g/L、酵母萃 取物 5 g/L、NaCl 10 g/L。 (3) GST清洗/結合緩衝液140 mM NaCl、10 mM Na2HP04、1.8 mM KH2P〇4、2.7 mM KC卜 O.lmM PMSF,pH 7.3 ° (4) GST洗提緩衝液50 mM Tris-HCl、10 mM還原榖 胱甘肽(glutathione)、0.1 mM PMSF,pH 8.0。 (5 ) 6X 負荷緩衝液(Loading buffer) 300 mM Tris-HCl ,pH 6.8、12% SDS、0.6%漠紛藍(Bromophenol blue )、60%甘油、6% β-硫氫乙醇。In the Osing test method, 'the biometric component contained in the work area is not specially controlled for the dioxin detection device', as long as it can be used with Dioxin or Dioxin Preferably, the monoclonal antibody, the plurality of anti-canine, the second parent == and/or the aromatic tobacco are subjected to a heteronuclear translocation protein, and more preferably an aromatic tobacco body and a fragrant hydrocarbon receptor nuclear translocator. In a specific embodiment of the invention, the dioxin-detecting device is used in the working region of the electrode comprising the aryl hydrocarbon receptor nuclear translocator. Since the aryl hydrocarbon receptor nuclear translocator specificity is combined with the aryl hydrocarbon receptor-Dioxin complex, step (2) can be modified to: the test sample is first reacted with an excess aromatic hydrocarbon receptor, and then the dioxin detection device is Contact with the test sample and detect its current signal Δ I i in the matrix-containing electrochemical buffer. The present invention and other related objects, features and advantages will be more apparent from the aspects of the appended claims. [Examples] Example 1 Preparation of Aromatic Hydrocarbon Receptor The medium and buffer used in this example were as follows: (1) Medium for protein expression, LB medium, Ampicillin (Amp) (final concentration 100 pg/ml) ), chloramphenicol (Cm) (final concentration 34Hg / ml). (2) LB medium · Tryptone 10 g/L, yeast extract 5 g/L, NaCl 10 g/L. (3) GST wash/binding buffer 140 mM NaCl, 10 mM Na2HP04, 1.8 mM KH2P〇4, 2.7 mM KC, O.lmM PMSF, pH 7.3 ° (4) GST elution buffer 50 mM Tris-HCl, 10 mM reduced glutathione, 0.1 mM PMSF, pH 8.0. (5) 6X Loading buffer 300 mM Tris-HCl, pH 6.8, 12% SDS, 0.6% Bromophenol blue, 60% glycerol, 6% β-thioethanol.

(6) SDS-PAGE 電泳緩衝液(Running buffer) 25 mM 16 200928357(6) SDS-PAGE running buffer 25 mM 16 200928357

Tris-HC卜 pH 8.3、250 mM 甘胺酸、0.1% SDS。 (7)芳香烴受體儲存緩衝液:50 mM Tris-HCl,pH 7.4 、500 mM NaCh ImM DTT、0.1% NP-40、O.lmM PMSF ° (a)將芳香烴受體配位體結合區DNA選殖到載體pGEX-4Tl 上 依 NCBI 網站(http://www.ncbi.nlm.nih.gov/index.html) 所揭示關於小鼠肝臟芳香烴受體基因mRNA之文獻設計芳 ® 香烴受體蛋白配位體結合片段的引子,並在引子前加上 Xhol切位CTCGAG。接著以小鼠肝臟總RNA ( Stratagene, €&1#736509,1^(^#1010139)為模板,利用反轉錄酶將1111^八 反轉錄為cDNA,以此cDNA為模板,用PCR方式大量擴 增芳香烴受體配位體結合片段DNA。依照topo TA選殖套 組步驟將芳香烴受體DNA接到topo載體上,利用藍白篩 方式選取有接入插入物的選殖株,放大培養後送定序。選 取定序正確之選殖株,放大培養後抽取質體DNA,利用Xhol ® 切下插入物,將插入物在膠上純化後,接入一樣由Xhol切 過的pGEX_4Tl載體,並轉形到R〇setta(DE3)plysS勝任細 胞(competent cell)中,塗抹在含Amp/Cm的LB培養盤 上0/N。挑選9個菌落,加到3ml含Amp/Cm抗生素的LB 培養基中放大培養,並在ODgoo大約0.8時加入最終1 mM IPTG誘導蛋白表現,誘導溫度37度,時間四小時。以 SDS-PAGE看這9個選殖株的蛋白表現,選取正確表現大小 的選殖株,以含Amp/Cm抗生素的LB培養基培養至〇D_ 17 200928357 . 大約1·〇,加入最終濃度10%甘油,冰入-80度冰箱保存。 (b) 大量表現GST-芳香烴受體蛋白 要大量表現芳香烴受體蛋白前一晚,先將保存菌液取 ΙΟΟμΙ加到l〇ml含Amp/Cm抗生素的LB培養基培養0/N 作為種菌’當天將種菌加到1L含Amp/Cm抗生素的LB培 養基,以37度培養到〇d6〇g大約0.6,移到20度震盪器待 溫度穩定後,加入最終濃度ImM IPTG誘導16〜20小時, 誘導完畢之菌液離心後可凍入-80度冰箱保存。Tris-HC Bu pH 8.3, 250 mM glycine, 0.1% SDS. (7) Aromatic hydrocarbon receptor storage buffer: 50 mM Tris-HCl, pH 7.4, 500 mM NaCh ImM DTT, 0.1% NP-40, O.lmM PMSF ° (a) Aromatic hydrocarbon receptor ligand binding region DNA was cloned into the vector pGEX-4Tl. According to the NCBI website (http://www.ncbi.nlm.nih.gov/index.html), the literature on the expression of aryl hydrocarbon receptor mRNA in mouse liver was designed. The acceptor protein ligand binds to the primer and adds the Xhol-cut CTCGAG to the primer. Then, using mouse liver total RNA ( Stratagene, €&1#736509,1^(^#1010139) as a template, reverse transcription was used to reverse-transform 1111^8 into cDNA, and this cDNA was used as a template and a large number of PCR methods were used. Amplification of the aryl hydrocarbon receptor ligand-binding fragment DNA. The aryl hydrocarbon receptor DNA was ligated to the topo vector according to the topo TA selection kit step, and the selection strain with the insertion insert was selected by blue-white sieve method to enlarge After culture, the sequence is selected. The correct sequence is selected, the plastid DNA is extracted after amplification, the insert is cut with Xhol ® , the insert is purified on the gel, and the pGEX_4Tl vector cut by Xhol is inserted. And transformed into R〇setta (DE3) plysS competent cell, smeared on Amp/Cm LB plate 0/N. Pick 9 colonies, add 3ml LB containing Amp/Cm antibiotic The culture medium was amplified and the final 1 mM IPTG induced protein was added at ODgoo of about 0.8, and the induction temperature was 37 °C for four hours. The protein performance of the nine selected strains was determined by SDS-PAGE, and the correct expression size was selected. Colony, cultured in LB medium containing Amp/Cm antibiotics to 〇D_ 17 200928357 . About 1 〇, add the final concentration of 10% glycerol, and store it in the refrigerator at -80 °C. (b) A large number of GST-aromatic hydrocarbon receptor proteins should be expressed in large quantities before the aryl hydrocarbon receptor protein. Add ΙΟΟμΙ to l〇ml LB medium containing Amp/Cm antibiotics to culture 0/N as an inoculum. Add the inoculum to 1L of LB medium containing Amp/Cm antibiotics, and incubate at 37 degrees to 〇d6〇g about 0.6. After moving to a 20-degree oscillator for temperature stability, the final concentration of ImM IPTG was added to induce 16 to 20 hours. After the induced bacteria solution was centrifuged, it was frozen and stored in a -80 degree refrigerator.

D (c) 以GST管柱及凝膠過濾管柱純化芳香烴受體蛋白 誘導完畢之菌體以〜100 ml PBS緩衝液(含〇. 1 mM PMSF)回溶均勻,利用細胞均質機打破細胞,破菌液加入最 終濃度0.1% NP-40及最終濃度300mM NaCl,以12000 rpm 離心一小時去除不可溶雜質,上清液以〇.22μιη濾膜過濾後 ,接著將上清液導入連接GST管柱的AKTA prime FPLC, 以GST清洗/結合缓衝液來進行沖洗,再以GST洗析緩衝 液將芳香烴受體蛋白自樹脂上脫附下來出來。利用UV280 ® 追蹤蛋白濾份,並以SDS-PAGE作雙重確認。將此粗純化 蛋白以Amicon過滤器濃縮到〜200μ1。將粗純化蛋白導入連 接丙稀葡聚酷(sephacryl ) S-200凝膠過滤管柱的 AKTAprime FPLC,以芳香烴受體貯藏緩衝液(store buffer )洗提,同時利用UV280追蹤蛋白濾份,並以SDS-PAGE 作雙重確認。將此二次純化蛋白以Amicon過濾器濃縮到 〜500μ1 ° (d) 蛋白質定量 200928357 利用Bio-Rad蛋白質試驗套組的試劑來測定蛋白質的 濃度。將所純化到的芳香烴受體蛋白利用Bradford方法來 檢測芳香烴受體蛋白的濃度。以牛血清白蛋白(Bovine Seriim Albumin,BSA)為蛋白質標準液,並分別配置成〇、 2、4、6、8、10 pg/ml等不同濃度,而待測樣本則以適當 倍數稀釋’再分別加入Bi〇-Rad蛋白質試驗套組的試劑進 行充分混合,在室溫下反應10分鐘後,於〇D595測定吸光 值’之後再藉由蛋白質標準液所獲得到的定量標準曲線, 即可換算出芳香烴受體蛋白的濃度,並分別取適當量的芳 香烴受體蛋白來進行蛋白質膠體電泳分析。 實施例2芳香烴受體核轉位蛋白製備 本實施例如實施例1所使用之培養基及緩衝液進行。 (a)將芳香烴受體核轉位蛋白與芳香烴受體結合區DNA選 殖到載體PGEX-4T1上 依 NCBI 網站(http://www.ncbi.nlm.nih.gov/index.html) 上所揭示關於小鼠肝臟芳香烴受體核轉位蛋白 gene 〇 mRNA之文獻設計芳香烴受體核轉位蛋白配位體結合片段 的引子。引子設計如下:向前引子(Forword primer ) :5,GGAACTGGCAACACATCTACT3’,位於基因序歹第 486 號核苷酸-506號核苦酸反向引子(Reverseword primer) :5’TGTAGGCCGTGGTTCCTGGCT3’,位於基因序列第 1458 號核苷酸-1478號核苷酸,接著以小鼠肝臟總RNA為模板 ,利用反轉錄酶將mRNA反轉錄為cDNA,以此cDNA為 模板,用PCR方式大量擴增芳香烴受體核轉位蛋白配位體 19 200928357 結合片段DNA。依照topo ΤΑ選殖套組步驟將芳香烴受體 核轉位蛋白DNA接到topo載體上,利用藍白篩方式選取 有接入插入物的選殖株,放大培養後送定序。選取定序正 確之選殖株,放大培養後抽取質體DNA,利用topo載體上 已有的EcoRI切位切下插入物,將插入物在膠上純化後, 接入一樣由EcoRI切過的pGEX-4Tl載體,並轉形到 Rosetta(DE3)plysS勝任細胞中,塗抹在含Amp/Cm的LB 培養盤上培養0/N。挑選9個菌落,加到3ml含Amp/Cm β 抗生素的LB培養基中放大培養,並在OD6()()大約0.8時加 入最終濃度ImM IPTG誘導蛋白表現,誘導溫度37度,時 間四小時。以SDS-PAGE看這9個選殖株的蛋白表現,選 取正確表現大小的選殖株,以含Amp/Cm抗生素的LB培養 基培養至〇D6〇〇大約1.0,加入最終濃度10%甘油,冰入-80 度冰箱保存。 (b) 大量表現GST-芳香烴受體核轉位蛋白 要大量表現芳香烴受體核轉位蛋白前一晚,先將保存 ® 菌液取100μ1加到10ml含Amp/Cm抗生素的LB培養基培 養0/N作為種菌,當天將種菌加到1L含Amp/Cm抗生素 的LB培養基,以37度培養到OD_大約0.6,移到20度 震盪器待溫度穩定後,加入最終濃度ImM IPTG誘導16〜20 小時,誘導完畢之菌液離心後可凍入-80度冰箱保存。 (c) 以GST管柱及凝膠過濾管柱純化芳香烴受體核轉位蛋白 誘導完畢之菌體以〜100ml PBS緩衝液(含0.ImM PMSF)回溶均勻,利用細胞均質機打破細胞,破菌液加入最 20 200928357 終濃度0.1% NP-40及最終濃度300 mM NaCl’以12000 rpm 離心一小時去除不可溶雜質,上清液以0.22 μηι濾、膜過遽後 ,接著將上清液導入連接GST管柱的AKTAprime FPLC, 以GST清洗/結合緩衝液來進行沖洗,再以GST洗提緩衝 液將芳香烴受體核轉位蛋白自樹脂上脫附下來出來。利用 UV280追蹤蛋白濾份(fraction),並以SDS-PAGE雙重確 認。將此粗純化蛋白以Amicon過濾器濃縮到〜200μ1。將粗 純化蛋白導入連接Sephacryl S-200凝膠過濾管柱的 & AKTAprime FPLC,以芳香烴受體核轉位蛋白儲存緩衝液洗 提,同時利用UV280追蹤蛋白濾份,並以SDS-PAGE雙重 確認。將此二次純化蛋白以Amicon過濾器濃縮到〜5〇〇μ1 〇 (d)蛋白質定量 利用Bio-Rad蛋白質分析套組的試劑來測定蛋白質的 濃度。將所純化到的芳香烴受體核轉位蛋白利用Bradford 方法來檢測芳香烴受體核轉位蛋白的濃度。以牛血清白蛋 ❹白為蛋白質標準液,並分別配置成〇、2、4、6、8、10 pg/ml 等不同濃度,而待測樣本則以適當倍數稀釋,再分別加入 Bio-Rad蛋白質分析套組的試劑進行充分混合,在室溫下反 應10分鐘後,於〇D595測定吸光值,之後再藉由蛋白質標 準液所獲得到的定量標準曲線’即可換算出芳香烴受體核 轉位蛋白的濃度,並分別取適當量的芳香烴受體核轉位蛋 白來進行蛋白質膠體電泳分析。 實施例3檢測裝置試片之製備 21 200928357 本實施例採用網印電極(SPE;購自泰博(巧營)科技股 份有限公司)製備本發明之檢測裝置,該檢測裝置1〇〇結 構係如第1圖所示,包含一 PVC材質之 電極刚,其位於該基板町;一工作二,其J 该基板102上且不與該參考電極1〇4接觸;一工作區域ι〇8 ,其位於工作電極106上;及一 pvc絕緣層ιι〇。網印電 極之基材為PVC材質,網印碳膠共分三道程序,首先針對 ❹工作區域1〇8以外之區域刷上銀膠,而後針對工作區域108 第一與二層以純碳膠進行網印,第三層則視需要以適當比 例之碳膠與普魯士藍(比例可隨所需而調整,普魯士藍比例 越高電流值越大)進行印刷,最後再覆蓋上一藍色pv=絕緣 層。由第1圖中可明顯看出,放大工作區域2〇8的面積目 的在於增加生物辨認元件與電子媒介物之固定量,以提升 電流輸出訊號’同時降低偵測極限之下限。 (a)物理包埋 ❹ 取其上已網印、塗膜或電聚合普魯士藍之網印電極試 片’以去離子水清洗後與空氣中風乾丨小時,將芳香烴受 1或芳香烴受體核轉位蛋白與明膠、纖維素、拉波尼特或 聚乙烯醇縮丁醛溶液(6-9%)以適當比例混合(通常為體積比 1·!^’取適當量(4-20μΕ)固定於工作區域2〇8上(芳香烴受體 或芳香烴欠體核轉位蛋白固定量約2〇 ng至約62 3 片) 二1 4 C乾燥2小時後,將其浸於2.5%戊二醛溶液中1〇 刀在里,再以去離子水清洗後,保存pBS_KCL_NP4()緩衝溶 液中。 22 200928357 (b)共價鍵結 取其上已網印PB之網印電極試片,以去離子水清洗後 與空氣中風乾1小時,將穀胱甘肽(glutathione; GHS)與明 膠或纖維素以適當比例混合(通常為體積比1:1)取適當量D (c) Purify the aryl hydrocarbon receptor protein-purified cells by GST column and gel filtration column. Dissolve the cells in ~100 ml PBS buffer (containing 〇. 1 mM PMSF) and break the cells with a cell homogenizer. The bacterial solution was added to a final concentration of 0.1% NP-40 and a final concentration of 300 mM NaCl, and centrifuged at 12,000 rpm for one hour to remove insoluble impurities. The supernatant was filtered through a 22.22 μιη filter, and then the supernatant was introduced into a GST tube. The column was AKTA prime FPLC, rinsed with GST wash/binding buffer, and the aromatic hydrocarbon receptor protein was desorbed from the resin in GST elution buffer. The protein fraction was traced using UV280 ® and double confirmed by SDS-PAGE. This crude purified protein was concentrated to ~200 μl with an Amicon filter. The crude purified protein was introduced into AKTAprime FPLC connected to a Sephacryl S-200 gel filtration column, eluted with an aromatic hydrocarbon receptor storage buffer, and the protein buffer was traced by UV280, and Double confirmation by SDS-PAGE. This secondary purified protein was concentrated to an amicon filter to ~500 μl (d) Protein quantification 200928357 The protein concentration was determined using the reagents of the Bio-Rad Protein Assay Kit. The purified aryl hydrocarbon receptor protein was used to detect the concentration of the aryl hydrocarbon receptor protein using the Bradford method. Bovine Seriim Albumin (BSA) was used as a protein standard solution and was set to different concentrations such as 〇, 2, 4, 6, 8, 10 pg/ml, and the samples to be tested were diluted with appropriate multiples. The reagents of the Bi〇-Rad protein test kit were separately mixed and reacted at room temperature for 10 minutes, and then the absorbance value of 〇D595 was measured, and then the quantitative standard curve obtained by the protein standard solution was used. The concentration of the aromatic hydrocarbon receptor protein was extracted, and an appropriate amount of the aromatic hydrocarbon receptor protein was separately taken for protein colloidal electrophoresis analysis. Example 2 Preparation of Aryl Hydrocarbon Receptor Nuclear Transposable Protein The present invention was carried out in the same manner as in the medium and buffer used in Example 1. (a) The aryl hydrocarbon receptor nuclear translocator and the aryl hydrocarbon receptor binding region DNA were selected on the vector PGEX-4T1 according to the NCBI website (http://www.ncbi.nlm.nih.gov/index.html) The literature disclosed above for the mouse liver aryl hydrocarbon receptor nuclear translocator gene 〇 mRNA is designed to introduce an aryl hydrocarbon receptor nuclear translocator ligand binding fragment. The primer design is as follows: Forword primer: 5, GGAACTGGCAACACATCTACT3', located in the nucleotide sequence No. 486 of the gene sequence Re - Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Reverse Nucleotide 1458 nucleotide -1478, followed by mouse liver total RNA as a template, reverse transcription of mRNA into cDNA using reverse transcriptase, using this cDNA as a template, large-scale amplification of aromatic hydrocarbon receptor core by PCR Translocator Ligand 19 200928357 Binding fragment DNA. According to the topo selection procedure, the aryl hydrocarbon receptor nuclear translocator DNA was ligated to the topo vector, and the selection strain with the insertion insert was selected by blue-white sieve method, and then amplified and cultured for sequencing. Select the correct sequencing strain, extract the plastid DNA after amplification, and cut the insert by using the existing EcoRI cleavage on the topo vector. After the insert is purified on the gel, the pGEX cut by EcoRI is inserted. -4Tl vector, and transformed into Rosetta (DE3) plysS competent cells, smeared on Amp/Cm-containing LB culture plate to culture 0/N. Nine colonies were selected and cultured in 3 ml of LB medium containing Amp/Cm β antibiotics, and protein expression was induced by adding a final concentration of 1 mM IPTG at an OD6()() of about 0.8, and the induction temperature was 37 degrees for four hours. The protein performance of the 9 selected strains was observed by SDS-PAGE. The correct size and size of the selected strains were selected and cultured in LB medium containing Amp/Cm antibiotics to 〇D6〇〇 about 1.0, and the final concentration of 10% glycerol was added. Store in an -80 degree refrigerator. (b) A large number of GST-aromatic hydrocarbon receptor nuclear transposons are required to express a large amount of aryl hydrocarbon receptor nuclear translocator one night. First, 100 μl of the preservation solution is added to 10 ml of LB medium containing Amp/Cm antibiotics. 0/N as an inoculum, the inoculum was added to 1L of LB medium containing Amp/Cm antibiotics, and cultured at 37 degrees to OD_about 0.6. After moving to a 20-degree oscillator for temperature stability, the final concentration of ImM IPTG was added to induce 16~ After 20 hours, the induced bacteria solution can be frozen and stored in a -80 degree refrigerator. (c) Purification of the aryl hydrocarbon receptor nuclear translocator by GST column and gel filtration column. The cells were uniformly dissolved in ~100 ml PBS buffer (containing 0.1 MmM PMSF), and the cells were disrupted by a cell homogenizer. The bacteria solution was added to the most 20 200928357 final concentration 0.1% NP-40 and the final concentration of 300 mM NaCl' was centrifuged at 12000 rpm for one hour to remove insoluble impurities, and the supernatant was filtered at 0.22 μηη, the membrane was passed through, and then the supernatant was The liquid was introduced into an AKTAprime FPLC connected to a GST column, washed with GST washing/binding buffer, and the aromatic hydrocarbon receptor nuclear translocator was desorbed from the resin in a GST elution buffer. The protein fraction was followed by UV280 and confirmed by SDS-PAGE. This crude purified protein was concentrated to ~200 μl with an Amicon filter. The crude purified protein was introduced into & AKTAprime FPLC connected to Sephacryl S-200 gel filtration column, eluted with aryl hydrocarbon receptor nuclear translocation protein storage buffer, and the protein buffer was traced by UV280 and doubled by SDS-PAGE. confirm. This secondary purified protein was concentrated to ~5 〇〇μ1 using an Amicon filter. (d) Protein quantification The protein concentration was determined using the reagent of the Bio-Rad Protein Assay Kit. The purified aryl hydrocarbon receptor nuclear translocator was assayed for the concentration of the aryl hydrocarbon receptor nuclear translocator using the Bradford method. The bovine serum white egg white was used as the protein standard solution, and was set to different concentrations such as 〇, 2, 4, 6, 8, 10 pg/ml, and the samples to be tested were diluted with appropriate multiples, and then added to Bio-Rad. The reagents of the protein analysis kit are thoroughly mixed, and after reacting for 10 minutes at room temperature, the absorbance is measured at 〇D595, and then the aryl hydrocarbon acceptor nucleus can be converted by the quantitative standard curve obtained by the protein standard solution. The concentration of the transposable protein was taken and the appropriate amount of the aromatic hydrocarbon receptor nuclear translocator was separately taken for protein colloidal electrophoresis analysis. Example 3 Preparation of test piece of test device 21 200928357 This embodiment uses a screen printing electrode (SPE; purchased from Taibo (Qiaoying) Technology Co., Ltd.) to prepare the detecting device of the present invention, and the structure of the detecting device is as follows. 1 shows an electrode comprising a PVC material, which is located in the substrate; a second operation, J is on the substrate 102 and is not in contact with the reference electrode 1〇4; a working area ι〇8 is located at work On the electrode 106; and a pvc insulation layer ιι〇. The substrate of the screen printing electrode is made of PVC material, and the screen printing carbon glue is divided into three procedures. First, the silver glue is applied to the area other than the ❹ working area 1 〇 8 , and then the first and second layers of the working area 108 are made of pure carbon glue. Screen printing, the third layer will be printed with the appropriate proportion of carbon glue and Prussian blue (the ratio can be adjusted as needed, the higher the Prussian blue ratio is, the higher the current value), and finally covered with a blue pv=insulation Floor. As is apparent from Fig. 1, the area of the enlarged working area 2〇8 is intended to increase the fixed amount of the biometric element and the electronic medium to increase the current output signal' while lowering the lower limit of the detection limit. (a) Physical embedding 网 Screen printing electrode film on which screen printing, film coating or electropolymerization of Prussian blue is taken. After washing with deionized water and drying with air stroke, the aromatic hydrocarbon is subjected to 1 or aromatic hydrocarbons. The nuclear translocation protein is mixed with gelatin, cellulose, Raponet or polyvinyl butyral solution (6-9%) in an appropriate ratio (usually a volume ratio of 1·!^' is taken in an appropriate amount (4-20 μΕ) ) is fixed on the working area 2〇8 (the aromatic hydrocarbon receptor or the aromatic hydrocarbon minus-nuclear transposable protein is fixed in an amount of about 2〇ng to about 62 3 pieces). After drying for 2 hours at 2 1 C, it is immersed in 2.5%. In the glutaraldehyde solution, the 1 knives are in the solution, and then washed with deionized water, and then stored in the buffer solution of pBS_KCL_NP4(). 22 200928357 (b) Covalently bonded to the screen printed electrode test piece on which the PB has been screen printed, After washing with deionized water and air drying for 1 hour, mix glutathione (GHS) with gelatin or cellulose in an appropriate ratio (usually 1:1 by volume).

❿ (2-20 pL)固定於工作區域208上。風乾後,將芳香烴受體 或芳香烴受體核轉位蛋白以浸泡或滴上之模式固定至電極 表面,本發明所生產之芳香烴受體與芳香烴受體核轉位蛋 白均具有GST終端,其可與網印電極表面已固定之穀胱甘 肽形成緊密結合),乾燥後,將其浸於2.5%戊二醛溶液中 ίο分知,再以去離子水清洗後,保存於pbs kcl_np4〇緩 衝办液中此法與物理包埋的方式相比較,程序雖較為複 雜’但可確保芳香烴受體或芳$烴受體核轉位蛋白均位於 電極表面,因而可提升卫作區域之有效固定量與結合位數 目0 實施例4本發明檢測裝置試片之功能與穩定性測試 =測試依上述實施例所製備之本發明檢測裝置試片 ::產生電流訊號且其訊號是否穩定。f 2圖為固定不 百分比普魯士藍/碳膠量並以明膠包埋芳香烴受體之 之i 片,在添加不同Η2〇2濃度下電流訊號值 ;被!大:顯示實施例中所添加之h2〇2確實 時杳天力曰曰·、士藍還原,進而產生還原電流訊號,同 】二=(即H2〇2與、士藍接觸量)變化時,電流訊 23 200928357 確認所製備之檢測裝置試片的穩定性, ,:片曰(碳膠與普魯士藍比為10:1)進行相同條:之: 、,只夕二人測置。在操作電壓_0.2V下,於第200 Η2〇2時多次測量之電流訊號如第3圖所示 〇 = 次電流❹】差異性並不大。 U顯不3 實施例5戴奥辛之測量 (1)以本發明檢測裝置試片測量戴奥辛之步驟 1. =保存於4它所製備完成之檢測裝置試片於室溫中回 溫9 2. 電化學分析儀在Amper〇metdc Μ曲線方法及設定之 條件下進行偵測。偵測時測試基質為電化學緩衝液i 〇 mL置於有磁性叙轉棒之燒杯中同時間進行授拌。開 始測試時平衡電流必須降至9〇〇xl〇_7 Amp以下將 10 mM之基質H2〇2加入緩衝液中偵測電流變化3〇〇 秒’得AI。值。 Ο 3. 摘測完成之檢測裝置試片使用緩衝液攪拌清洗並靜 置於加蓋之試管中。 4. 將戴奥辛標準液與純有機溶劑(DMs◦或甲醇、丙嗣、 壬規)以體冑1:1之比例混合。再吸取不同體積之戴奥 辛/有機溶劑標準液溶解於2mL電化學測試液中以獲 得所需要標準濃度測試液(有機溶劑之 0.5-0.2%之間)。 5·將已知之不同戴奥辛稀釋濃度與檢測裝置試片在抽 風櫃中進行試驗。將步驟3試管甲之檢測裝置試片浸 24 200928357 泡在總體積2 mL戴奥辛溶液中15分鐘進行反應。 取出檢測裝置試片罟入2 mT. Φ 进_ .❿ (2-20 pL) is fixed to the work area 208. After air drying, the aromatic hydrocarbon receptor or the aromatic hydrocarbon receptor nuclear translocator is immobilized to the electrode surface in a soaking or dropping mode, and the aromatic hydrocarbon receptor and the aromatic hydrocarbon receptor nuclear translocator produced by the present invention both have GST. a terminal which can form a tight bond with the glutathione which has been fixed on the surface of the screen printing electrode. After drying, it is immersed in a 2.5% glutaraldehyde solution, and then separated by deionized water and stored in pbs. In the kcl_np4 buffer solution, this method is more complicated than the physical embedding method, but the procedure is to ensure that the aromatic hydrocarbon receptor or the aromatic hydrocarbon acceptor is located on the surface of the electrode, thereby enhancing the protective region. The effective fixed amount and the number of binding bits are 0. Example 4 The function and stability test of the test piece of the detecting device of the present invention=Testing the test piece of the detecting device of the present invention prepared according to the above embodiment: generating a current signal and whether the signal is stable. The f 2 picture shows the amount of Prussian blue/carbon glue fixed and the i-block of the aromatic hydrocarbon receptor embedded in gelatin. The current signal value is added at different concentrations of Η2〇2; Large: It shows that the h2〇2 added in the embodiment is indeed reduced by 杳天力曰曰·,士蓝, and then the reduction current signal is generated, and when the second = (that is, the contact amount of H2〇2 and Shilan) changes, Current News 23 200928357 Confirm the stability of the test piece prepared by the test device. The film: (the ratio of carbon glue to Prussian blue is 10:1) is the same::,, and only two people are measured. At the operating voltage _0.2V, the current signal measured multiple times at the 200th Η2〇2 is as shown in Fig. 3 〇 = secondary current ❹] The difference is not large. U 显 3 Example 5 Measurement of dioxin (1) Step of measuring dioxin by the test piece of the detection device of the invention 1. Saved in 4 The test piece prepared by the test device is tempered at room temperature 9 2. Electrochemistry The analyzer is tested under the Amper〇metdc curve method and settings. At the time of detection, the test substrate was an electrochemical buffer i 〇 mL placed in a beaker with a magnetic revolving rod while being mixed. The balance current must be reduced to 9〇〇xl〇_7 Amp at the start of the test. Add 10 mM of substrate H2〇2 to the buffer to detect a change in current of 3 sec. value. Ο 3. The test piece of the test device completed by the test is washed with a buffer and placed in a capped test tube. 4. Mix the dioxin standard solution with pure organic solvent (DMs® or methanol, propylene glycol, hydrazine) in a ratio of 1:1. The different volumes of the dioxin/organic solvent standard solution were dissolved in 2 mL of the electrochemical test solution to obtain the required standard concentration test solution (between 0.5 and 0.2% of the organic solvent). 5. Test the known dioxins dilution concentration and the test device test piece in the draft cabinet. The test piece of the test tube of the test tube of step 3 was immersed in 24 200928357 and bubbled in a total volume of 2 mL of the dioxin solution for 15 minutes. Take out the test piece and insert 2 mT. Φ into _.

之試管中保存。 7.將反應後並攪拌清洗過之檢測裝置試片在電化學分 析儀上使用Amperometric i-t曲線方法及步驟2相同 條件進行該檢測裝置試片之第二次偵測,得△ ^值,依 ❺ IR = (ΔΙο-ΔνΜ^χ丨00%計算電流下降率,電流訊號大 小之數據採用Amperometric i-t曲線方法中最後丨〇秒 之數據平均值。 (2)工作區域上芳香烴受體有效固定量增加對電流下降 之提升效應 於本發明檢測裝置試片上漸次增加芳香烴受體之固定 量,由原本之20 ng提升至62.3 ,測量電流下降率。表 1表示不同^香烴受體固定量下,戴奥辛濃度與電流下降率 之情況。 G表1:不同芳香煙受體固定量(perSPE)下不同濃度TCDD之 電流下降率值Store in a test tube. 7. After the reaction, the test piece of the test device is stirred and cleaned, and the second detection of the test piece of the test device is performed on the electrochemical analyzer using the Amperometric it curve method and the same condition in step 2, and the Δ ^ value is obtained. IR = (ΔΙο-ΔνΜ^χ丨00% calculates the current drop rate, the data of the current signal size is the average value of the last leap seconds in the Amperometric it curve method. (2) The effective fixed amount of aromatic hydrocarbon receptors in the working area increases. The effect of increasing the current drop on the test piece of the detection device of the present invention gradually increases the fixed amount of the aromatic hydrocarbon receptor, from the original 20 ng to 62.3, and measures the current drop rate. Table 1 shows the fixed amount of the different aroma hydrocarbon receptors, Dioxin concentration and current rate of decline. G Table 1: Current decline rate values of different concentrations of TCDD under different aromatic smoke receptors (perSPE)

由表1可看 片漸次提升至7. 可看出當芳香烴受體之固定量由原本之2〇 ng/ I 7.5 μέ/片時,由於試片上可與TCDD結合之 25 200928357 活性位置增加因此電流下^ ^ ^ ^ 著TCDD漠声并古而総丄 電抓下降率隨 ,辰度升间而變大,顯示確實有更多的TCDD* 一 5式片上的芳香烴受體相結合。但當固定於 !受體量提升至62、時’則由於工作區域表面幾::: 芳㈣受體完全覆蓋,在此情況下不僅工作區域 之方香烴梵體結合位置因幾何阻礙而外 ❹ ❿ ^香煙,舊可與TCDD結合,但因== 卜 某當3於松實’此時芳香煙受體與TCDD結合所造成之 質擴散阻礙反而無法凸顯,因此電流下降率變化不大。 結果顯示每片檢測裝置試片上固^ :香烴受體’即21.43 ng/mm2~〇13盹/麵2 電流下降率測量結果。 于H又佳之 (3)戴奥辛濃度與電流下降率之關係 =當之芳香烴受體固定量〇 2 W每片試片)與 (1GmM)’·電極之最終製程針對不同濃度之 ;作相對應之檢量線,結果如第4圖所示。由該圖可 出在-定濃度範圍之内,TCDD濃度與電流差值 關係。 實施例6它種戴奥辛分子之測量 依實施例5之步驟,檢測他種戴奥辛分子之測試,選 (六氯二苯并〔M〕°夫喃)進行測量,確認芳香 ;又,、TCDD之外的戴奥辛分子間的結合能力,結果如 Trnn及5Β圖所示。由該圖可看出芳香烴受體除了可與 、、σ 口外,亦可與HxCDF結合,且電流下降的情況隨 26 200928357 著濃度提升而漸漸變大。 上述實施例僅為示範性且不應視為本發明之限制。 呈教示可應用在其他類型裝置。說明書内容旨在更詳盡= 明本發明,並不應以此限制本發明之申請專利範圍。 β 產業可利用性 ° 由本文可知,本發明之檢測裝置除了可用於tcdd之 偵測外,亦可用於其他戴奥辛/類戴奥辛物質之偵測,達到 ❹符合現行法規TCDD總量管制之目標。此外,經由調整本 發=檢測裝置上芳香烴受體之固定量,獲得適用於各種濃 度fe圍之簡易快速、可現地檢測的戴奥辛檢測裝置,可檢 測大濃度範圍(0_1000ppt)與小濃度範圍(〇卜丨⑼卯丨)之戴奥 辛/類戴奥辛物質之濃度。 ’、 【圖式簡單說明】 第1圖為本發明戴奥辛檢測裝置之示意圖。 ❹第2圖為固定不同重量百分比PB/碳膠量並以明膠包埋芳 香煙文體之本發明檢測裝置’在添加不同H2〇2濃度下電流 訊號值之變化圖。 第3圖為塗佈芳香烴受體之檢測裴置試片進行3次It can be seen from Table 1 that the tablet is gradually increased to 7. It can be seen that when the fixed amount of the aromatic hydrocarbon receptor is from 2 ng/I 7.5 μέ/tablet, the active position of the 25 200928357 can be combined with the TCDD on the test piece. Under the current ^ ^ ^ ^ TCDD indifference and ancient and 総丄 総丄 抓 抓 下降 下降 , , , , , , , , , , , , 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 , , , , , , , , However, when the amount of the receptor is increased to 62, the surface of the working area is completely covered by a few::: aromatic (four) receptors. In this case, not only the position of the aromatic hydrocarbons in the working area is geometrically hindered. ❹ ❿ ^ Cigarettes, which can be combined with TCDD, but because of the == Bu Mou 3 is loose, the mass diffusion barrier caused by the combination of the aromatic smoke receptor and TCDD can not be highlighted, so the current drop rate does not change much. The results showed that the current measurement rate of the solids: aroma hydrocarbon receptors on each test piece was 21.43 ng/mm2~〇13盹/surface 2 . (H) The relationship between the concentration of dioxin and the rate of current drop = when the aryl hydrocarbon receptor is fixed 〇 2 W per piece) and the final process of (1G mM)' electrode is for different concentrations; The calibration curve, the results are shown in Figure 4. From this graph, the relationship between the TCDD concentration and the current difference can be found within the -concentration concentration range. Example 6 The measurement of the dioxin molecule was carried out according to the procedure of Example 5, and the test of the dioxin molecule was tested, and the measurement was carried out by selecting (hexachlorodibenzo[M] °), confirming the aroma; and, other than TCDD The binding ability of the Dioxin molecule is shown in the results of Trnn and 5Β. It can be seen from the figure that the aromatic hydrocarbon receptor can be combined with HxCDF in addition to the σ port, and the current drop gradually increases with the increase of the concentration of 26 200928357. The above embodiments are merely exemplary and should not be construed as limiting the invention. Teaching can be applied to other types of devices. The contents of the specification are intended to be more detailed. The invention is not intended to limit the scope of the invention. β Industry Availability ° As can be seen from the description, the detection device of the present invention can be used for the detection of tcdd, and can also be used for the detection of other dioxin/dioxine-like substances, and achieves the goal of complying with the current regulations TCDD total amount control. In addition, by adjusting the fixed amount of the aromatic hydrocarbon receptor on the detection device to obtain a simple, rapid and reproducible detection of various concentrations of the dioxin detection device, the large concentration range (0_1000 ppt) and the small concentration range can be detected ( The concentration of dioxin/dioxine-like substance in 〇卜丨(9)卯丨). ‘, BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a schematic view of a dioxin detecting device of the present invention. Fig. 2 is a graph showing changes in current signal values of the detection device of the present invention in which different amounts of PB/carbon glue are fixed and the aromatic cigarette style is embedded in gelatin. Figure 3 is a test strip for coating an aromatic hydrocarbon receptor.

Amperometric i-t曲線偵測的結果。 第4圖為不同濃度下之tCdD濃度與電流差值之關係。 第5 A及5β圖為不同濃度HxCDF所產生之電流差值。 【主要元件符號說明】 27 200928357 100 檢測裝置 102 基板 104 參考電極 106 工作電極 108 工作區域 110 絕緣層The result of Amperometric i-t curve detection. Figure 4 shows the relationship between the concentration of tCdD and the current difference at different concentrations. The 5A and 5β plots show the difference in current produced by different concentrations of HxCDF. [Main component symbol description] 27 200928357 100 Detection device 102 Substrate 104 Reference electrode 106 Working electrode 108 Working area 110 Insulation

Claims (1)

200928357 、申請專利範圍 1. -種戴奥辛檢測方法,其包含: (1)將一生物辨認元件及一電子媒介物固定於一電極 表面; (2 將該電極置於含基質之溶液中,測量第一氧化 原電流訊號; (3)將該電極與含戴奥辛或類戴奥辛物質樣本接觸, ❹ ii將電極置於含基質之溶液中,測量第二氧化還 原電流訊號;及 (4) 獲付第一及第二氧化還原電流訊號差值,並盥含 戴奥辛或類戴奥辛物質之標準溶液及其相對應電 流訊號差值比較’決定該樣本中戴奥辛或類戴奧 辛物質之濃度。 ’、 其中該 其中該 芳香烴 2·如申請專利範圍第i項所述之戴奥辛檢測方法 生物辨認元件為親戴奥辛物質。 ❿3.如中請專利範圍第2項所述之戴奥辛檢測方法 生=辨認兀件為單株抗體、多株抗體、多胜肽,^ 又體(Aryl Hydrocarbon Recept〇r ; A 受體核轉位蛋白(Aryl Hydr一 。 飞 工 y rocarbon Receptor Nuclear rranslocator ; ARNT)。 4. 2請專利範圍第3項所述之戴奥辛檢測方法,其中該 生=辨=件為芳香煙受體或芳香烴受體。 請專,P項所述之戴奥辛檢測方法,其中該 電子媒介物係選自包括普魯士藍(p—ian _ 29 200928357 potassium hexacyanoferrate)、麥爾多拉氏藍(Meldola Blue, MB, 8-dimethylamino-2,3-benzophenoxazine)、對苯 酿(p-Benzoquinone ; p-BQ )、鄰苯二胺( o-phenylenediamine ; o-PDA )、二氯盼散基齡 (dichlorophenolindophenol DCPIP)、3,4-二經苯曱酸 (3,4-dihydroxybenzaldehyde ; 3,4-DHB) > 苯曱基紫精( benzyl viologen)、及其混合物之群組。 6. ❹ 7. 8. ❿ 9. 10 11 如申請專利範圍第1項所述之戴奥辛檢測方法,其中該 基質為H202、NADH、NADPH及/或其混合物。 一種戴奥辛檢測裝置,其包含: 一基板; 一參考電極,其係位於該基板上;及 一工作電極,其係位於該基板上且不與該參考電極接觸 ,該工作電極包括一工作區域,該工作區域中包括有生 物辨認元件及電子媒介物。 如申請專利範圍第7項所述之戴奥辛檢測裝置,其中該 生物辨認元件為親戴奥辛物質。 如申請專利範圍第8項所述之戴奥辛檢測裝置,其中該 生物辨認元件為單株抗體、多株抗體、多胜肽、芳香烴 受體及/或芳香烴受體核轉位蛋白。 如申請專利範圍第9項所述之戴奥辛檢測裝置,其中 該生物辨認元件為芳香烴受體或芳香烴受體核轉位蛋白 〇 如申請專利範圍第7項所述之戴奥辛檢測裝置,其中 30 200928357 、麥爾多拉氏藍、對 3,4-二羥苯甲醛、苯 該電子媒介物係選自包括普魯士藍 苯醌、鄰苯二胺、二氯酚靛基酚、 甲基紫精、及其混合物之群組。 12. 中 如申請專利範圍第11項所述 該電子媒介物為普魯士藍。 之戴奥辛檢測裝置 其 項所述之戴奥辛檢測裝置,其中 、纖維素、拉波尼特(Laponite200928357, the scope of patent application 1. A method for detecting dioxin, comprising: (1) fixing a biometric component and an electron mediator to an electrode surface; (2 placing the electrode in a solution containing a matrix, measuring a monoxide current signal; (3) contacting the electrode with a sample containing dioxin or a dioxin-like substance, ❹ ii placing the electrode in a solution containing the substrate, measuring a second redox current signal; and (4) receiving the first And the second redox current signal difference, and the comparison between the standard solution containing the dioxin or the dioxin-like substance and the corresponding current signal difference 'determines the concentration of the dioxin or dioxin-like substance in the sample. ', wherein the fragrance Hydrocarbon 2· The biological recognition element of the dioxin detection method described in item yi of the patent application is a dioxin substance. ❿ 3. The dioxin detection method described in item 2 of the patent scope is as follows: the identification element is a monoclonal antibody, Multiple antibodies, polypeptides, and Aryl Hydrocarbon Recept〇r; A receptor nuclear translocator (Aryl Hydr I. Flying y rocarbon Rec Eptor Nuclear rranslocator; ARNT) 4. 2 Please refer to the dioxin detection method described in item 3 of the patent scope, in which the student = identification = aromatic smoke receptor or aromatic hydrocarbon receptor. Please, specifically, the dioxin described in item P The detection method, wherein the electron mediator is selected from the group consisting of Prussian blue (p-ian _ 29 200928357 potassium hexacyanoferrate), Meldola Blue (MB, 8-dimethylamino-2, 3-benzophenoxazine), and benzene (p-Benzoquinone; p-BQ), o-phenylenediamine (o-PDA), dichlorophenolindophenol DCPIP, 3,4-dibenzoic acid (3,4- Dihydroxybenzaldehyde; 3,4-DHB) > Groups of benzyl viologen, and mixtures thereof 6. ❹ 7. 8. ❿ 9. 10 11 Dioxin as described in claim 1 The detection method, wherein the substrate is H202, NADH, NADPH, and/or a mixture thereof. A dioxin detection device comprising: a substrate; a reference electrode on the substrate; and a working electrode disposed on the substrate Up and not connected to the reference electrode The working electrode comprises a work area, the work area including animate object identification device and an electronic vehicle. The dioxin detecting device according to claim 7, wherein the biometric component is a dioxin substance. The dioxin detecting device according to claim 8, wherein the biometric element is a monoclonal antibody, a multi-drug antibody, a multi-peptide, an aromatic hydrocarbon receptor, and/or an aromatic hydrocarbon receptor nuclear translocator. The dioxin detecting device according to claim 9, wherein the biometric element is an aryl hydrocarbon receptor or an aryl hydrocarbon receptor nuclear translocator, such as the dioxin detecting device according to claim 7 of the patent application, wherein 30 200928357, Merdo Lac, blue 3,4-dihydroxybenzaldehyde, benzene. The electron mediator is selected from the group consisting of Prussian blue benzoquinone, o-phenylenediamine, dichlorophenol nonylphenol, methyl viologen, And a group of its mixtures. 12. Medium The electronic medium described in item 11 of the patent application is Prussian Blue. The dioxin detection device of the dioxin detection device, wherein, cellulose, Laponite ❹ 13. 如申請專利範圍第7 該工作區域更包含明膠 )或聚乙烯醇縮丁酸:。 膠或纖維素 如中請專利範圍第7項所述之戴奥辛檢測裝置,且中 该工作電極之該工作區域更包括碳膠。 /、 16.如申請專利範圍第7項所述之戴奥辛檢測裝置,其中 =工作區域巾芳香烴受體或料烴受體核轉位蛋白之含 罝為 0.36ng/mm2〜l.ll pg/mm2。 17如申請專利範圍帛16項所述之戴奥辛檢測農置,盆 :該工作區域中芳香烴受體或芳香烴受體核轉位蛋白^ 3 量為 21.43 ng/mm2〜〇· 13 pg/mm2 0 18.種利用戴奥辛檢測裝置之戴奥辛檢測方法,其中該 戴奥辛檢測裝置包含: 一基板; 一參考電極,其係位於該基板上;及 工作電極,其係位於該基板上且不與該參考電極接觸 31 200928357 ,§亥工作電極包括一工作區域 物辨認元件及電子媒介物;且 该戴奥辛檢測方法包含: ⑴將該戴奥辛檢測裝置於含基質之電化學緩衝液中 偵測其電流訊號△ 1〇 ;❹ 13. If the patent application scope is 7th, the work area contains gelatin or polyvinyl butyrate: Glue or cellulose, such as the dioxin detection device described in claim 7, wherein the working area of the working electrode further comprises carbon glue. /, 16. The dioxin detection device according to claim 7, wherein the 工作 content of the aromatic hydrocarbon receptor or the hydrocarbon receptor nuclear translocation protein in the working area is 0.36 ng/mm2~l.ll pg/ Mm2. 17 As described in the scope of patent application 戴16, the dioxin detection farm, basin: the amount of aryl hydrocarbon receptor or aryl hydrocarbon receptor nuclear translocation protein ^ 3 in the working area is 21.43 ng / mm2 ~ 〇 · 13 pg / mm2 0 18. A dioxin detection method using a dioxin detection apparatus, wherein the dioxin detection apparatus comprises: a substrate; a reference electrode on the substrate; and a working electrode on the substrate and not corresponding to the reference electrode Contact 31 200928357, the working electrode of the hai includes a working area identification component and an electronic medium; and the dioxin detection method comprises: (1) detecting the current signal Δ 1〇 in the electrochemical buffer containing the matrix. ; (2)將该戴奥辛檢測裝置與檢測樣本接觸,並於含基 質之電化學緩衝液中摘測其電流訊號ΔΙ!; 土 ^3)測得ΔΙο與電流訊號差值; (4)將該電流訊號差值與含戴奥辛或類戴奥辛物質之 標準溶液及其相對應電流訊號差值比較,以決定 該樣本中戴奥辛或類戴奥辛物質之濃度。 .中=申請專利範圍第18項所述之戴奥辛檢測方法,其 土質為H2〇2、NADH、NADPH及/或其混合物。 二申請專利範圍第19項所述之戴奥辛檢測方法,其 γ 5亥基質為H2〇2。 ❹ 5亥工作區域中包括有生 中2、請專利範圍第18項所述之戴奥辛檢測方法,其 體:双測裝置中之工作電極的工作區域中包含芳香烴受 中兮4^、叫專利範圍帛18項所述之戴奥辛檢測方法,其 體:轉:ί:中之工作電極的工作區域中包含芳香烴受 法申料利11帛18項及22項所述之戴奥辛檢測方 、中步驟(2)為:將檢測樣本先與過量芳香煙受體 %再將該戴奥辛檢測裝置與該檢測樣本接 觸,並於 32 200928357 含基質之電化學緩衝液中偵測其電流訊號^。 專利範圍第18項所述之戴奥辛檢測方法,其 Ιίΐ :侧選自包括普魯士藍、麥爾多拉氏藍、 、鄰本二胺、二氯酚靛基酚、3,4-二羥苯甲醛、 本甲基紫精、及其混合物之群組。 A二2專利範圍· 24項所述之戴奥辛檢測方法,宜 中6亥電子媒介物為普魯士藍。 八 26. 乂申Γ專利範圍第18項所述之戴奥辛檢測方法,立 區域更包含明膠、纖維素、拉波尼特或聚乙稀 其 27. 中二:「專:18項所述之戴奥辛檢測震置, 中以㈣域更包含榖胱甘肽與明膠或纖維素。 其 认^申請專利範圍f 18項所述之戴奥辛檢測 中該工作電極之該工作區域更包括碳膠。 其 29如申料利犯圍第18項所述之戴奥辛檢測 區域中芳香烴受體或芳香烴受體核轉‘白 s 量為 0.36 ng/mm2〜Mi Hg/mm2。 之 3〇. ^申請專利範圍第29項所述之戴奥辛 IK區:中/芳香2烴受體或芳香烴受體核轉位2 為 21.43 ng/rtiiji 〜0.13 pg/mm2。 33(2) contacting the dioxin detection device with the test sample, and extracting the current signal ΔΙ!; in the electrochemical buffer containing the matrix; the earth ^3) measuring the difference between the ΔΙο and the current signal; (4) the current The signal difference is compared with a standard solution containing dioxin or dioxin-like material and its corresponding current signal difference to determine the concentration of dioxin or dioxin-like material in the sample. Medium = the dioxin detection method described in claim 18, the soil quality of which is H2〇2, NADH, NADPH and/or a mixture thereof. 2. The dioxin detection method described in claim 19, wherein the γ 5 hai matrix is H 2 〇 2 . ❹ The 5 hai working area includes the dioxin detection method described in item 2 of the patent scope. The body: the working area of the working electrode in the double measuring device contains the aromatic hydrocarbons. The dioxin detection method described in the 帛18 item, the body: the working area of the working electrode in the ί: the aromatic hydrocarbon is included in the method of claim 11, 11 and 22, the dioxin detection method, the middle step (2): the test sample is first contacted with the excess aromatic smoke receptor and the dioxin detection device is contacted with the test sample, and the current signal is detected in the electrochemical buffer containing the substrate in 32 200928357. The dioxin detection method described in claim 18, wherein the side is selected from the group consisting of Prussian blue, Meldola blue, o-benzamine, dichlorophenol nonylphenol, 3,4-dihydroxybenzaldehyde , a group of the present methyl viologen, and mixtures thereof. A 2 2 patent range · 24 items of the dioxin detection method, Yizhong 6 Hai electronic medium is Prussian blue. VIII 26. The dioxin detection method described in item 18 of the patent application scope, the vertical area further contains gelatin, cellulose, rabonite or polyethylene. 27. Secondary: "Special: 18 In the detection of the shock, the (4) domain further comprises glutathione and gelatin or cellulose. The working area of the working electrode in the dioxin detection described in claim 18 of the patent application includes carbon glue. The application of the aryl hydrocarbon receptor or aryl hydrocarbon acceptor in the dioxin detection zone described in Item 18 is 0.36 ng/mm2~Mi Hg/mm2. In the 29th Dioxin IK zone: the nuclear translocation 2 of the medium/aromatic 2 hydrocarbon acceptor or aryl hydrocarbon acceptor is 21.43 ng/rtiiji ~0.13 pg/mm2.
TW096150572A 2007-12-27 2007-12-27 A device for detecting the dioxin and a method of detection thereof TWI368028B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW096150572A TWI368028B (en) 2007-12-27 2007-12-27 A device for detecting the dioxin and a method of detection thereof
JP2008179268A JP2009156859A (en) 2007-12-27 2008-07-09 Method for measuring dioxins and measurement device used for the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW096150572A TWI368028B (en) 2007-12-27 2007-12-27 A device for detecting the dioxin and a method of detection thereof

Publications (2)

Publication Number Publication Date
TW200928357A true TW200928357A (en) 2009-07-01
TWI368028B TWI368028B (en) 2012-07-11

Family

ID=40961017

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096150572A TWI368028B (en) 2007-12-27 2007-12-27 A device for detecting the dioxin and a method of detection thereof

Country Status (2)

Country Link
JP (1) JP2009156859A (en)
TW (1) TWI368028B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI682337B (en) * 2018-12-03 2020-01-11 元進莊企業股份有限公司 Food safety quality and efficiency monitoring system and method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3699756B2 (en) * 1995-10-30 2005-09-28 アークレイ株式会社 Method for measuring hydrogen peroxide, hydrogen peroxide measuring sensor using the method, and method for producing the same
JP4574828B2 (en) * 2000-10-03 2010-11-04 株式会社インテリジェントセンサーテクノロジー Taste inspection method and taste inspection apparatus
JP2004264174A (en) * 2003-03-03 2004-09-24 Kansai Electric Power Co Inc:The Aryl hydrocarbon receptor fixing electrode, manufacturing method and application of the same
JP4654411B2 (en) * 2005-03-25 2011-03-23 独立行政法人産業技術総合研究所 Hydrogen peroxide concentration measurement method, enzyme activity measurement method and immunochemical measurement method
JP2006275819A (en) * 2005-03-29 2006-10-12 Cci Corp Biosensor

Also Published As

Publication number Publication date
JP2009156859A (en) 2009-07-16
TWI368028B (en) 2012-07-11

Similar Documents

Publication Publication Date Title
Rycroft et al. Activity of acetyltransferase toxins involved in Salmonella persister formation during macrophage infection
Gagic et al. Current trends in detection of histamine in food and beverages
Ozawa et al. Split luciferase as an optical probe for detecting protein− protein interactions in mammalian cells based on protein splicing
Scott et al. Genetically engineered bacteria: electrochemical sensing systems for antimonite and arsenite
Michelini et al. A new recombinant cell-based bioluminescent assay for sensitive androgen-like compound detection
Behzadian et al. Construction and characterization of Escherichia coli whole-cell biosensors for toluene and related compounds
Garmendia et al. Tracing explosives in soil with transcriptional regulators of Pseudomonas putida evolved for responding to nitrotoluenes
Zhang et al. Development of an analytical method for the determination of β2-agonist residues in animal tissues by high-performance liquid chromatography with on-line electrogenerated [Cu (HIO6) 2] 5--luminol chemiluminescence detection
Roy et al. Tunable multiplexed whole-cell biosensors as environmental diagnostics for ppb-level detection of aromatic pollutants
Gu et al. Toxicity monitoring and classification of endocrine disrupting chemicals (EDCs) using recombinant bioluminescent bacteria
O'Banion et al. Design and profiling of a subcellular targeted optogenetic cAMP-dependent protein kinase
Lopreside et al. Prêt-à-porter nanoYESα and nanoYESβ bioluminescent cell biosensors for ultrarapid and sensitive screening of endocrine-disrupting chemicals
Jin et al. A label-free impedimetric immunosensor for detection of 1-aminohydantoin residue in food samples based on sol–gel embedding antibody
Kim et al. Construction of engineered fructosyl peptidyl oxidase for enzyme sensor applications under normal atmospheric conditions
Shi et al. Development of a sensitive phage-mimotope and horseradish peroxidase based electrochemical immunosensor for detection of O, O-dimethyl organophosphorus pesticides
Xu et al. Flow injection chemiluminescent competitive immunoassay for the β-adrenergic agonist salbutamol using carboxylic resin beads and enzymatic amplification
Laschi et al. Polychlorinated biphenyls (PCBs) detection in food samples using an electrochemical immunosensor
Özyurt et al. MerR‐fluorescent protein chimera biosensor for fast and sensitive detection of Hg2+ in drinking water
Bettazzi et al. Development of an electrochemical immunoassay for the detection of polybrominated diphenyl ethers (PBDEs)
CN112763562B (en) Preparation method of branch-shaped walking machine aptamer electrochemical sensor for adenosine triphosphate detection
Castillo et al. Electrochemical and photometric detection of plasmin by specific peptide substrate
Cheng et al. Electrochemiluminescence immunosensor based on platinum electrode modified with TiO2@ ATO nanocomposite for sensitive detection of AFB1
Li et al. Clopyralid detection by using a molecularly imprinted electrochemical luminescence sensor based on the “gate-controlled” effect
Zhang et al. Capillary electrophoresis-based immunoassay for the determination of brevetoxin-B in shellfish using electrochemical detection
TW200928357A (en) A device for detecting the dioxin and a method of detection thereof